Egetis Therapeutics AB (publ) announced three key appointments to medical affairs and the commercial team to deliver on activities to ensure successful launches after anticipated approvals of Emcitate in USA and Europe in 2024. Marianne Berrens-Peijnenburg joins as Global Head of Medical Affairs, Nadia Georges joins as Global Head of Market Access & Pricing, and Peter Verwaijen joins as Global Head of Marketing & Brand Strategy. Marianne Berrens-Peijnenburg has previously had international and senior roles at companies such as Santhera, Sanofi Genzyme and J&J. Marianne will be based in The Netherlands.

Nadia Georges brings experience from global and international roles at companies such as Ferring, Takeda and Sanofi. Nadia will be based in Switzerland. Peter Verwaijen has previously had international and senior positions at companies such as Santhera, Roche and Actelion.

Peter will be based in The Netherlands.